ABL Bio Inc (298380) — Cash Flow Quality Index
ABL Bio Inc (298380) has a Cash Flow Quality Index of 0.96x as of June 2025. Operating cash flow of ₩38.30 Billion is below net income of ₩39.78 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 298380 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ABL Bio Inc Cash Flow Quality Index (2022–2022)
Historical Cash Flow Quality Index for ABL Bio Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of ABL Bio Inc to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for ABL Bio Inc (2022–2022)
Year-by-year earnings quality comparison for ABL Bio Inc. For live market cap and the full company financial profile, see 298380 market cap.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 22.48x | ₩72.13 Billion | ₩3.21 Billion | — |